Prognostic value of heart rate reserve in patients with suspected coronary artery disease undergoing stress myocardial perfusion imaging.
MPI
SPECT
diagnostic and prognostic application
Journal
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
29
03
2021
accepted:
01
07
2021
pubmed:
5
8
2021
medline:
15
10
2022
entrez:
4
8
2021
Statut:
ppublish
Résumé
Chronotropic incompetence is common in patients with cardiovascular disease and is associated with increased risk of adverse events. We assessed the incremental prognostic value of heart rate reserve (HRR) over stress myocardial perfusion single-photon emission computed tomography (MPS) findings in patients with suspected coronary artery disease (CAD). We studied 866 patients with suspected CAD undergoing exercise stress-MPS as part of their diagnostic program. The primary study endpoint was all-cause mortality. All patients were followed for at least 5 years. HRR was calculated as the difference between peak exercise and resting HR, divided by the difference of age-predicted maximal and resting HR and expressed as percentage. During 7 years follow-up, 61 deaths occurred, with a 7% cumulative event rate. Patients experiencing death were older (P < .001), and had a higher prevalence of male gender (P < .001) and diabetes (P < .05). Patients with event also had lower values of HRR (65% ± 27% vs 73% ± 18%, P < .0001) and higher prevalence of stress-induced myocardial ischemia (25% vs 8%, P < .0001). Male gender, HRR and stress-induced ischemia were independent predictors of all-cause mortality (all P < .01). HRR improved the prognostic power of a model including clinical data and MPS findings, increasing the global χ Chronotropic incompetence has independent and incremental prognostic value in predicting all-cause mortality in patients with suspected CAD undergoing exercise stress-MPS. Hence, the evaluation of HRR may further improve patients' risk stratification.
Sections du résumé
BACKGROUND
Chronotropic incompetence is common in patients with cardiovascular disease and is associated with increased risk of adverse events. We assessed the incremental prognostic value of heart rate reserve (HRR) over stress myocardial perfusion single-photon emission computed tomography (MPS) findings in patients with suspected coronary artery disease (CAD).
METHODS
We studied 866 patients with suspected CAD undergoing exercise stress-MPS as part of their diagnostic program. The primary study endpoint was all-cause mortality. All patients were followed for at least 5 years. HRR was calculated as the difference between peak exercise and resting HR, divided by the difference of age-predicted maximal and resting HR and expressed as percentage.
RESULTS
During 7 years follow-up, 61 deaths occurred, with a 7% cumulative event rate. Patients experiencing death were older (P < .001), and had a higher prevalence of male gender (P < .001) and diabetes (P < .05). Patients with event also had lower values of HRR (65% ± 27% vs 73% ± 18%, P < .0001) and higher prevalence of stress-induced myocardial ischemia (25% vs 8%, P < .0001). Male gender, HRR and stress-induced ischemia were independent predictors of all-cause mortality (all P < .01). HRR improved the prognostic power of a model including clinical data and MPS findings, increasing the global χ
CONCLUSIONS
Chronotropic incompetence has independent and incremental prognostic value in predicting all-cause mortality in patients with suspected CAD undergoing exercise stress-MPS. Hence, the evaluation of HRR may further improve patients' risk stratification.
Identifiants
pubmed: 34346030
doi: 10.1007/s12350-021-02743-2
pii: 10.1007/s12350-021-02743-2
pmc: PMC9553802
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
2521-2530Informations de copyright
© 2021. The Author(s).
Références
J Nucl Cardiol. 2021 Dec;28(6):2676-2683
pubmed: 32166569
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2032-2041
pubmed: 31254034
JACC Heart Fail. 2013 Jun;1(3):259-66
pubmed: 24621878
J Nucl Cardiol. 2022 Feb;29(1):323-333
pubmed: 32601888
Am J Cardiol. 2020 Jun 1;125(11):1661-1665
pubmed: 32273056
Atherosclerosis. 2013 Apr;227(2):307-12
pubmed: 23375683
JACC Cardiovasc Imaging. 2018 Jul;11(7):1000-1009
pubmed: 29055639
N Engl J Med. 2005 Nov 3;353(18):1889-98
pubmed: 16267320
Biometrics. 1983 Sep;39(3):665-74
pubmed: 6652201
N Engl J Med. 1979 Jun 14;300(24):1350-8
pubmed: 440357
Eur Cardiol. 2019 Apr;14(1):13-17
pubmed: 31131032
J Nucl Cardiol. 2018 Oct;25(5):1616-1620
pubmed: 30069820
Eur J Nucl Med Mol Imaging. 2015 Nov;42(12):1929-40
pubmed: 26290421
J Nucl Cardiol. 2020 Apr;27(2):547-557
pubmed: 30027504
Can J Cardiol. 2012 Mar-Apr;28(2):201-7
pubmed: 22336522
Am J Cardiol. 2019 Sep 15;124(6):972-977
pubmed: 31324358
Cancer. 1950 Jan;3(1):32-5
pubmed: 15405679
J Nucl Cardiol. 2021 Dec;28(6):2799-2807
pubmed: 32383079
J Am Coll Cardiol. 2004 Jul 21;44(2):423-30
pubmed: 15261942
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
J Am Coll Cardiol. 2010 Jan 19;55(3):221-30
pubmed: 19913381
Med Sci Sports Exerc. 2002 Dec;34(12):1873-8
pubmed: 12471290
J Nucl Cardiol. 2021 Oct;28(5):1891-1902
pubmed: 31823327
J Nucl Cardiol. 2011 Dec;18(6):1086-94
pubmed: 21785922
Atherosclerosis. 2020 Oct;310:45-53
pubmed: 32890806
Am Heart J. 2011 Aug;162(2):356-62
pubmed: 21835298
Am J Cardiol. 2015 Dec 1;116(11):1678-84
pubmed: 26482180
Circulation. 1996 Apr 15;93(8):1520-6
pubmed: 8608620
J Nucl Cardiol. 2004 Jul-Aug;11(4):414-23
pubmed: 15295410
Circulation. 2003 Jun 17;107(23):2894-9
pubmed: 12796141
Eur J Appl Physiol. 2009 Jan;105(1):37-45
pubmed: 18797918